The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
Consortium to Establish a Registry for Alzheimer's Disease (CERAD): The first twenty years
Open accessAbstract
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) was funded by the National Institute on Aging in 1986 to develop standardized, validated measures for the assessment of Alzheimer's disease (AD). The present report describes the measures that CERAD developed during its first decade and their continued use in their original and translated forms. These measures include clinical, neuropsychological, neuropathologic, and behavioral assessments of AD and also assessment of family history and parkinsonism in AD. An approach to evaluating neuroimages did not meet the standards desired. Further evaluations that could not be completed because of lack of funding (but where some materials are available) include evaluation of very severe AD and of service use and need by patient and caregiver. The information that was developed in the U.S. and abroad permits standardized assessment of AD in clinical practice, facilitates epidemiologic studies, and provides information valuable for individual and public health planning. CERAD materials and data remain available for those wishing to use them.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Diagnostic and Statistical Manual of Mental Disorders
&NA; (1988) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-198802020-00022 · Cited by 12,526
A New Clinical Scale for the Staging of Dementia
Hughes, C. P., Berg, L., Danziger, W., Coben, L. A., & Martin, R. L. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.140.6.566 · Cited by 7,056
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Self-citationMoms, J. C., Heyman, A., Mohs, R. C., Hughes, J. P., van Belle, G., Fillenbaum, G., Mellits, E. D., & Clark, C. (1989) · Neurology · doi:10.1212/wnl.39.9.1159 · Cited by 4,130
Self-citationBlessed, G., Tomlinson, B. E., & Roth, M. (1968) · British Journal of Psychiatry · doi:10.1192/bjp.114.512.797 · Cited by 4,117
Cited by
Auriel, E., Charidimou, A., Gurol, M. E., Ni, J., Van Etten, E. S., Martinez-Ramirez, S., Boulouis, G., Piazza, F., DiFrancesco, J. C., Frosch, M. P., et al. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2015.4078 · Cited by 359
The amyloid cascade hypothesis: an updated critical review
Kepp, K. P., Robakis, N. K., Høilund-Carlsen, P. F., Sensi, S. L., & Vissel, B. (2023) · Brain · doi:10.1093/brain/awad159 · Cited by 284
Sherman, D. S., Mauser, J., Nuno, M., & Sherzai, D. (2017) · Neuropsychology Review · doi:10.1007/s11065-017-9363-3 · Cited by 281
Thompson, R., Smith, R. B., Bou Karim, Y., Shen, C., Drummond, K., Teng, C., & Toledano, M. B. (2022) · Environment International · doi:10.1016/j.envint.2021.106905 · Cited by 280
Lachman, M. E., Agrigoroaei, S., Tun, P. A., & Weaver, S. L. (2014) · Assessment · doi:10.1177/1073191113508807 · Cited by 256
Tau-positron emission tomography correlates with neuropathology findings.
Lowe, V. J., Lundt, E. S., Albertson, S. M., Min, H., Fang, P., Przybelski, S. A., Senjem, M. L., Schwarz, C. G., Kantarci, K., Boeve, B., et al. (2020) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.09.079 · Cited by 203
DELANO-WOOD, L., BONDI, M. W., SACCO, J., ABELES, N., JAK, A. J., LIBON, D. J., & BOZOKI, A. (2009) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617709990257 · Cited by 155
“…to Establish a Registry for Alzheimer’s Disease (CERAD; Welsh, Butters, & Mohs, 1994 ), a reliable, well-standardized neuropsychological battery often used to detect impairment in mildly impaired populations (Chandler et al., 2005 ; Fillenbaum et al., 2008 ; Schmidtke & Hermeneit, 2007 ).”
BackgroundThe three-dimensional landscape of cortical chromatin accessibility in Alzheimer’s disease
Bendl, J., Hauberg, M. E., Girdhar, K., Im, E., Vicari, J. M., Rahman, S., Fernando, M. B., Townsley, K. G., Dong, P., Misir, R., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01166-7 · Cited by 65
Translational approaches to understanding resilience to Alzheimer’s disease
Neuner, S. M., Telpoukhovskaia, M., Menon, V., O’Connell, K. M. S., Hohman, T. J., & Kaczorowski, C. C. (2022) · Trends in Neurosciences · doi:10.1016/j.tins.2022.02.005 · Cited by 68
“Historically, this has been done postmortem using classifications from autopsy-based neuropathological scores on standardized scales such as the Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) score for neuritic plaques [78] and Braak staging of neurofibrillary tangles [79] in combination with antem…”
MethodMicroglial motility in Alzheimer’s disease and after Aβ42 immunotherapy: a human post-mortem study
Franco-Bocanegra, D. K., George, B., Lau, L. C., Holmes, C., Nicoll, J. A. R., & Boche, D. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0828-x · Cited by 64
Microglial Activation and Connectivity in Alzheimer Disease and Aging
Rauchmann, B., Brendel, M., Franzmeier, N., Trappmann, L., Zaganjori, M., Ersoezlue, E., Morenas‐Rodriguez, E., Guersel, S., Burow, L., Kurz, C., et al. (2022) · Annals of Neurology · doi:10.1002/ana.26465 · Cited by 61
Chan, J. S., Wibral, M., Stawowsky, C., Brandl, M., Helbling, S., Naumer, M. J., Kaiser, J., & Wollstadt, P. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.631599 · Cited by 49
Stein, J., Luppa, M., Luck, T., Maier, W., Wagner, M., Daerr, M., van den Bussche, H., Zimmermann, T., Köhler, M., Bickel, H., et al. (2012) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e318209dd08 · Cited by 35
Stoner, C. R., Lakshminarayanan, M., Durgante, H., & Spector, A. (2021) · Aging & Mental Health · doi:10.1080/13607863.2019.1695742 · Cited by 35
Association between thyroid function and Alzheimer's disease: A systematic review
Figueroa, P. B. S., Ferreira, A. F. F., Britto, L. R., Doussoulin, A. P., & Torrão, A. D. S. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00760-1 · Cited by 28
Aguirre-Acevedo, D. C., Jaimes-Barragán, F., Henao, E., Tirado, V., Muñoz, C., Reiman, E. M., Tariot, P. N., Langbaum, J. B., & Lopera, F. (2016) · International Psychogeriatrics · doi:10.1017/s1041610215001660 · Cited by 25
Self-citationVillamil-Ortiz, J. G., Barrera-Ocampo, A., Arias-Londoño, J. D., Villegas, A., Lopera, F., & Cardona-Gómez, G. P. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170554 · Cited by 24
Supasitthumrong, T., Tunvirachaisakul, C., Aniwattanapong, D., Tangwongchai, S., Chuchuen, P., Tawankanjanachot, I., Snabboon, T., Hemrungrojn, S., Carvalho, A. F., & Maes, M. (2019) · Journal of Alzheimer’s Disease · doi:10.3233/jad-190114 · Cited by 13
Metadata
- Authors
- Fillenbaum, G. G., van Belle, G., Morris, J. C., Mohs, R. C., Mirra, S. S., Davis, P. C., Tariot, P. N., Silverman, J. M., Clark, C. M., Welsh-Bohmer, K. A., & Heyman, A.
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2008-03
- Volume
- 4
- Issue
- 2
- Pages
- 96-109
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W2053675728
- Cited by
- 482
- References
- 111
- FWCI
- 5.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.